Guest guest Posted May 8, 2006 Report Share Posted May 8, 2006 In the local news(1) this week was announced the creation of a web portal making available medical research and " health-related information " from the USA to the Chinese " consumers and health professionals. " Expected launch date is sometime this summer. The participants are Bridgetech Holdings International Inc (Solana Beach/San Diego, " a company focused on maximizing the potential of emerging healthcare products and services in China and the U.S., " ) for the implementation, Stanford University School of Medicine and Texas A & M Health Center, presumably for the data, and Chine's Wu Jieping Medical Foundation. Wu Jieping is an organ of the PRC Ministry of Health, founded in 2002. " The mission of this charitable organization is to promote and, ultimately, introduce state-of-the-art healthcare products and services to the medical community and consumers alike. The CEO of Bridgetech is quoted as describing the venture as " satisfying a demand for Western medicine among Chinese consumers, many of whom still rely on traditional or herbal remedies to treat illness. " Mention is made of expected growth of the Chinese middle class from 250 million to 600 million in by 2020. Like the younger generation Chinese hightech workers here in Silicon Valley, it seems the Chinese middle class is being conditioned to and become consumers of WM. Around here (Silicon Valley), it's mainly the older family members who have immigrated here who patronize the local TCM practitioners. I bring this up here as the quotation above ( " many… still rely on traditional .. remedies " ) struck me as further confirmation of the notion, documented by Kim Taylor and Paul Unschuld, among others, that TCM continues marching along a path of planned obsolescence. That is, the quotation could be interpreted to connote that the Chinese middle class will probably gravitate to WM when given the opportunity (availability and marketing), and most certainly if the government promotes it. " Bridgetech has longstanding relationships with leading healthcare organizations both in the U.S and China and close ties to government, regulatory and business communities in both countries. " (from their website) The BridgeTech site appears to focus on marketing and financial aspects. Another notice (March 6) announces " they have established a new entity to distribute Bridgetech's products throughout the Peoples Republic of China (PRC). " The agreement is with the Wu JiePing Medical Foundation, which " works with an extensive member network of more than 300 of China's most esteemed hospitals. " In another announcement, (BridgeTech partnere with Ch. Univ. of Hong Kong), mention is made: " This relationship will also facilitate additional research on Traditional Chinese Medicines flowing back through leading research institutions in the U.S. " 1) In the " Palo Alto Daily News " , Monday May 1, from PR by Stanford University, which is situated at Palo Alto. According the Bridgetech website, the original announcement was on April 10. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.